GTC will be closed today in observance of Thanksgiving, we will reopen tomorrow with normal business hours.??
Genomic Testing Cooperative
生物技术研究
Lake Forest，California 2,905 位关注者
Making Genomics Available and Affordable for Everyone
关于我们
Our Mission is to create a diagnostic service that provides access to advanced genomic testing in communities everywhere. Our testing provides answers for ALL cancers covering both solid tumors and hematologic neoplasms. Genomic Testing Cooperative (GTC) is a different kind of cancer diagnostic laboratory. Our cooperative model allows us to partner with laboratories, hospitals, oncology practices and medical professionals to share resources which create efficiencies in cost, turnaround time and quality. In creating a network of Co-Op partners, we help get results to physicians faster, share knowledge and generate better outcomes for patients.
- 网站
-
https://genomictestingcooperative.com
Genomic Testing Cooperative的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- Lake Forest，California
- 类型
- 私人持股
- 创立
- 2018
- 领域
- Genomic testing、Precision Medicine、Next Gen Sequencing、Oncology、Hematology、Comprehensive Genomic Profiling、Leukemia、Lymphoma、Myeloma、Lung Cancer、Breast Cancer、Colon Cancer和CDx
地点
-
主要
获取路线
25371 Commercentre Dr
US，California，Lake Forest，92630
Genomic Testing Cooperative员工
-
Jeffrey Owen
Vice President, Marketing @ Genomic Testing Cooperative
-
Rachel Rosenberger
Lead Clinical Data Reporter at Genomic Testing Cooperative
-
Maher Albitar
Founder, Chief Executive Officer and Chief Medical Officer at Genomic Testing Cooperative
-
Jennifer Varca
Vice President, Business Development
动态
-
Learn how you can run comprehensive DNA and RNA panels for oncology and sign out NGS in your own lab. https://lnkd.in/dX4qRgfR #Interprestation #RNA #DNA
-
-
Check out our poster schedule: Clearance of Circulating Multiple Myeloma Cells to Assess Early Response to Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma? Number:?4687 Presenter:?Binod Dhakal Session:?653. Multiple Myeloma: Clinical and Epidemiological: Poster III Time and Location: Monday, December 9, 2024: 6:00 PM-8:00 PM Halls G-H (San Diego Convention Center) Clonotype-Na?ve Detection of Clonality in Patients Suspected of Having Multiple Myeloma or Monoclonal Gammopathy Using Peripheral Blood Cell-Free RNA (cfRNA) Number:?1946 Presenter:?Maher Albitar Program:?Oral and Poster Abstracts Session:?653. Multiple Myeloma: Clinical and Epidemiological: Poster I Time and Location: Saturday, December 7, 2024: 5:30 PM-7:30 PM Halls G-H (San Diego Convention Center)? Immune and Myeloid Differentiation Shape Transcriptome to Discriminate Evolutionary Stages of Cellular Transformation Number:?2923 Presenter:?Lacey Williams Program:?Oral and Poster Abstracts Session:?618. Acute Myeloid Leukemias: Biomarkers and Molecular Markers in Diagnosis and Prognosis: Poster II Time and Location: Sunday, December 8, 2024: 6:00 PM-8:00 PM Halls G-H (San Diego Convention Center)? Establishing a Distinct Cytokine Signature for Multiple Myeloma Using Bone Marrow RNA and Peripheral Blood Cell-Free RNA (cfRNA) Number:?3316 Presenter:?Maher Albitar Program:?Oral and Poster Abstracts Session:?653. Multiple Myeloma: Clinical and Epidemiological: Poster II Time and Location: Sunday, December 8, 2024: 6:00 PM-8:00 PM Halls G-H (San Diego Convention Center)? Establishing Distinct Cytokine Signatures Differentiating between Acute Myeloid Leukemia, Myelodysplastic Syndrome, and Chip Using Bone Marrow RNA or Cell-Free RNA (cfRNA) Number:?4295 Presenter:?Maher Albitar Program:?Oral and Poster Abstracts Session:?618. Acute Myeloid Leukemias: Biomarkers and Molecular Markers in Diagnosis and Prognosis: Poster III Time and Location: Monday, December 9, 2024: 6:00 PM-8:00 PM Halls G-H (San Diego Convention Center) Establishing Lymphoma Type-Specific Cytokine Signatures Using Tissue-Based RNA or Peripheral Blood Cell-Free RNA (cfRNA) Number:?4367 Presenter:?Maher Albitar Program:?Oral and Poster Abstracts Session:?621. Lymphomas: Translational – Molecular and Genetic: Poster III Time and Location: Monday, December 9, 2024: 6:00 PM-8:00 PM Halls G-H (San Diego Convention Center)? https://lnkd.in/e2D4Gzqr #ASH24 #Hematology #Leukemia #Lymphoma #Multiplemyeloma?
-
-
In collaboration with Menarini Silicon Biosystems our CEO/CMO will be part of their panel discussion at Society for Neuro-Oncology discussing Menarini Search: Improving Patient Outcomes with Enhanced CSF-Liquid Biopsy Testing for CNS Tumors and Leptomeningeal Disease. November 23, 2024 12:45-1:45PM George R. Brown Convention Center, Houston, TX - Room 332
-
-
Thank you to everyone who attended our Spotlight Theater yesterday at #AMP24
-
-
GTC wants to take a moment to acknowledge those ~62,000 Americans who will be diagnosed with pancreatic cancer. It is the cancer with the highest mortality rate. GTC is working to help better understand tumor biology and helping to identify new treatment options. Learn more about GTC's testing: ?https://lnkd.in/gBmGD6u #Worldpancreaticcancerday #pancreaticcancer
-
-
GTC is exhibiting at AMP 2024. Stop by and learn more about?our Interprestation software. Booth: #1623 https://lnkd.in/dX4qRgfR #AMP24 #Interprestation #molecularpathology
-
-
Stage Number:?Innovation Spotlight Stage #1 Innovation Spotlight Time:?4:25 PM - 4:55 PM Innovation Spotlight Date:?Thursday November 21, 2024 Innovation Spotlight Hosted By:?Genomic Testing Cooperative Innovation Spotlight Title:?The Role of RNA Sequencing in Cancer Molecular Profiling RNA Data Is Playing an Increasing Role in Determining Therapy, Augmenting Conventional Testing Including Flow Cytometry, Immunohistochemistry, FISH and Diagnostic Morphology
-
-
GTC is looking forward to AMP where we will be giving a talk in the exhibit spotlight theater #1 on Thursday at 4:25 and giving demonstrations of our Interprestation software. See you there! https://lnkd.in/dX4qRgfR #AMP24 #RNA #AI
-